SCHEMBL19110313

SCHEMBL19110313

c1ccc2c(c1)oc1ccc(-c3c4ccccc4c(-c4ccc5sc6c(ccc7c6ccc6c8ccccc8sc67)c5c4)c4ccccc34)cc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.40
ALDH1A1 P00352 3/20 0.40
HPGD P15428 3/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
NPC1 O15118 2/20 0.40
KDM4E B2RXH2 2/20 0.40
RAB9A P51151 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
ALOX5 P09917 1/20 0.38
AHR P35869 2/20 0.36
PRKDC P78527 1/20 0.36
ESR2 Q92731 2/20 0.35
GPR3 P46089 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C19 P33261 1/20 0.34
ESR1 P03372 1/20 0.34
HSP90AA1 P07900 1/20 0.34
HSP90AB1 P08238 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17944255 0.97 MAPT (0.40) MAPTALDH1A1HPGDMEN1KMT2A
SCHEMBL19110109 0.92 MAPT (0.38) MAPTALDH1A1HPGDMEN1KMT2A
SCHEMBL21388985 0.92 MAPT (0.44) MAPTALDH1A1HPGDMEN1KMT2A
SCHEMBL17945433 0.91 ALOX5 (0.44) MAPTALDH1A1HPGDMEN1KMT2A
SCHEMBL17247148 0.91 KDM4E (0.37) MAPTALDH1A1HPGDMEN1KMT2A
SCHEMBL19110315 0.91 MAPT (0.33) MAPTALDH1A1HPGDMEN1KMT2A
SCHEMBL23502075 0.90 MAPT (0.38) MAPTALDH1A1HPGDMEN1KMT2A
SCHEMBL19110136 0.90 ESR2 (0.39) MAPTALDH1A1HPGDMEN1KMT2A
SCHEMBL24341122 0.89 MAPT (0.34) MAPTALDH1A1HPGDMEN1KMT2A
SCHEMBL23426917 0.89 MAPT (0.41) MAPTALDH1A1HPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11276827-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2022-03-15 US disclosed
US-20170200905-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-13 US disclosed
US-20170200905-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170200905-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 MAPT 1538/4885ALDH1A1 237/4885HPGD 1696/4885
US-11276827-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 MAPT 1538/4885ALDH1A1 237/4885HPGD 1696/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.